3M. Angstwurm,J. Hoffmann,H. Ostermann,L. Frey,M. Spannagl.Schwere Sepsis und disseminierte intravasale Gerinnung[J]. Der Anaesthesist . 2009 (2)
4Johnston CC,Dowers SL,Urbanski RJ.Examination of the filtera-bility of oxygenated erythrocytes (containing normal,trait or sicklecell disease type hemoglobins)in the presence of L-epinephrine,D,L-isoproterenol or prostaglandins (PG)A1,A2,E1,E2,F1alphaor F2alpha. Prostaglandins . 1977
5Zhang Y,Guan DL,Xia CQ,et al.Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplan-tation. Transplantation Proceedings . 2005
6Tobari S,Ikeda Y,Takami H.Beneficial effects of intravenousadministration of lipo-prostaglandin E1 on the ischemic gastric tubein pigs. Journal of Surgical Research . 2005
7Kobayashi H,Katakura O,Morimoto N,et al.Effects of cholesterol-bearing pullulan (CHP)-nanogels in combination with prostaglandinE1 on wound healing. J Biomed Mater Res B Appl Biomater . 2009
8Alexandre LG,Garrett P,Norma S,et al.Inhibition of plateletGPIIb-IIIa and P-selectin expression by aspirin is impaired by stresshyperglycemia. Journal of Diabetes and Its Complications . 2009
9Mizushima Y,Hoshi K,Hamano T.Lipo-prostaglandin E1-develop-ment and targeted delivery of PGE1. J Jpn Coil Angiol . 1994
10Park MS,Martini WZ,Dubick MA,et al.Thromboelastography as abetter indicator of hypercoagulable state after injury than prothrombintime or activated partial thromboplastin time. The Journal of Trauma . 2009
